Actemra & Systemic Juvenile Idiopathic Arthritis « Rheumatoid Arthritis Guy
Links shared publicly online about this topic.
- 1,075total visits
Actemra & Systemic Juvenile Idiopathic Arthritis « Rheumatoid Arthritis Guy
View full resource at rheumatoidarthritisguy.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Juvenile Rheumatoid Arthritis, Children's Health, Actemra
Most Recently Shared on June 22, 2010 at 3:58 pm By:
Actemra & Systemic Juvenile Idiopathic Arthritis http://bit.ly/bCBnhI
Roche claims arthritis drug tops rival in trials - NEWS - General articles - Pharmaceutical Industry - PMLiVE
pmlive.com — “Pharmaceutical Industry | NEWS | General | Roche claims arthritis drug tops rival in trials - RoActemra reduces RA symptoms more effectively than Humira in phase IV trial | PMLiVE” View full resource at pmlive.com
Most Recently Shared on March 5, 2012 at 10:59 am By:
Roche claims arthritis drug tops rival in trials http://t.co/pUeo5qUF
Preliminary results from Genentech's ACTEMRA monotherapy study on RA
news-medical.net — “Genentech, a member of the Roche Group, today announced that preliminary results from the ADACTA (ADalimumab ACTemrA) study showed that patients who received ACTEMRA (tocilizumab) as monotherapy achieved a significantly greater reduction in disease activity after 24 weeks than those given adalimumab monotherapy.” View full resource at news-medical.net
Most Recently Shared on March 2, 2012 at 6:13 pm By:
Arthritis News: Preliminary results from Genentech's ACTEMRA monotherapy study on RA: Genentech, a member of the... http://t.co/J7dLGPXx
Jab that ends the agony of childhood arthritis: New NHS treatment brings relief to nine in ten young patients | Mail Online
dailymail.co.uk — “NICE has approved RoActemra (tocilizumab) to treat systemic juvenile idiopathic arthritis (sJIA) which is currently incurable.” View full resource at dailymail.co.uk
Most Recently Shared on February 4, 2012 at 11:25 pm By:
Jab that ends the agony of childhood arthritis: New NHS treatment brings ... http://t.co/UNyqvFt2
ACTEMRA (tocilizumab) | Rheumatoid Arthritis Treatment
actemra.com — “Find information about ACTEMRA, an FDA-approved treatment for rheumatoid arthritis. ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a Tumor Necrosis Factor (TNF) antagonist has been used and did not work well. ACTEMRA is used to treat people with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older. So” View full resource at actemra.com
Most Recently Shared on January 20, 2012 at 3:35 pm By:
RxEconsult, LLC - Actemra for rheumatoid arthritis and systemic juvenile idiopathic arthritis
rxeconsult.com — “RxEconsult, LLC - Actemra for rheumatoid arthritis and systemic juvenile idiopathic arthritis” View full resource at rxeconsult.com
Most Recently Shared on October 18, 2011 at 3:02 am By:
#Actemra for rheumatoid #arthritis and systemic juvenile idiopathic arthritis http://t.co/zPw6uiBI #Medications #healthcare
Mutant genes found for asthma, point to possible therapy | Reuters
reuters.com — “HONG KONG (Reuters) - A drug used to treat rheumatoid arthritis could help asthma patients, scientists said on Friday, as they identified two mutant genes that may predispose a person to asthma.Over” View full resource at reuters.com
Most Recently Shared on September 9, 2011 at 12:25 pm By:
Mutant genes found for asthma, point to possible therapy | Reuters - http://t.co/GsxeIf9
Mutant genes found for asthma, point to possible therapy | Reuters
reuters.com — “* Asthma may be linked to two mutant genes * Experts see use in rheumatoid arthritis drug for asthma By Tan Ee Lyn HONG KONG, Sept 9 (Reuters) - A drug used to treatrheumatoid arthritis could” View full resource at reuters.com
Most Recently Shared on September 9, 2011 at 6:16 am By:
Mutant genes discovery suggests Roche's Actemra may help in asthma ... http://t.co/tHYEZes
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on August 30, 2011 at 10:45 pm By:
Roche Trial Information:
roche-trials.com — “Roche Trial Information:” View full resource at roche-trials.com
Most Recently Shared on August 30, 2011 at 10:36 pm By:
@_connectedcare @ArtAppleADay Yes, & looks like they're recruiting in a # of countries http://t.co/qA8sDiE > #actemra clinical trials #AS
Key Account Specialist – Actemra Memphis | Walnut Creek Chiropractic
walnutcreekchiropractic.org — “Key Account Specialist – Actemra Memphis | Walnut Creek Chiropractic” View full resource at walnutcreekchiropractic.org
Most Recently Shared on August 12, 2011 at 1:27 am By:
#walnutcreek: Key Account Specialist - Actemra Memphis http://www.walnutcreekchiropractic.org/key-account-specialist-actemra-memphis-2/
Article > NICE seeks more info on RoActemra in childhood arthritis
pharmatimes.com — “Article > NICE seeks more info on RoActemra in childhood arthritis” View full resource at pharmatimes.com
Most Recently Shared on August 11, 2011 at 11:30 am By:
NICE wants more info on Roche's RoActemra for systemic juvenile arthritis. Comparative data, LT follow-up, etc. http://bit.ly/rhiIfQ
Key Account Specialist – Actemra Memphis | Walnut Creek Chiropractic
walnutcreekchiropractic.org — “Key Account Specialist – Actemra Memphis | Walnut Creek Chiropractic” View full resource at walnutcreekchiropractic.org
Most Recently Shared on July 29, 2011 at 4:54 pm By:
#walnutcreek: Key Account Specialist - Actemra Memphis http://www.walnutcreekchiropractic.org/key-account-specialist-actemra-memphis/
Is It Ethical To Use Placebo In Rheumatoid Arthritis Clinical Trials? - QualityPoint Technologies
qualitypointtech.net — “The results of this study, conducted in Germany, re-open the debate on whether it is ethical to conduct placebo-controlled studies where patients in the placebo-group are at a serious disadvantage compared to patients taking the new treatments. The study analysed current study designs, for new therapies such as abatacept (Orencia®), golimumab (Simponi®) or tocilizumab (Actemra®), and showed that patients in the placebo group experienced no change in medication, having to continue with their form” View full resource at qualitypointtech.net
Most Recently Shared on May 30, 2011 at 8:45 am By:
Is It Ethical To Use Placebo In Rheumatoid Arthritis Clinical Trials?: The results of this study, conducted in Ger... http://bit.ly/jzp1Bh
NICE guidance by date
guidance.nice.org.uk — “NICE guidance by date” View full resource at guidance.nice.org.uk
Most Recently Shared on April 27, 2011 at 8:36 am By:
NICE recommends golimumab (Simponi) for psoriatic arthritis and romiplostim (Nplate) for TTP: http://guidance.nice.org.uk/Date
FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
drugs.com — “Actemra (tocilizumab) is used to treat Rheumatoid Arthritis and Systemic Juvenile Idiopathic Arthritis . Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 19, 2011 at 4:12 am By:
FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA): SOU... http://bit.ly/h7x9uE #drug
Advertisement

